Guirui Yan

Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides

Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity

The Epidemiology of Obesity: A Big Picture

Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4)

Adipocytes under assault: Environmental disruption of adipose physiology

Trends in GPCR drug discovery: new agents, targets and indications

Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity

Differential Phosphorylation of Perilipin 1A at the Initiation of Lipolysis Revealed by Novel Monoclonal Antibodies and High Content Analysis

ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds

Artificial intelligence in drug development: present status and future prospects

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

Mechanisms of Insulin Action and Insulin Resistance

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

Citrate-based materials fuel human stem cells by metabonegenic regulation

Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides

Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Targeting orphan G protein‐coupled receptors for the treatment of diabetes and its complications: C‐peptide andGPR146

Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes

GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit

Tailoring the volatility and stability of oligopeptides

Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue

Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study

Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice

Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening

Sildenafil promotes adipogenesis through a PKG pathway

Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice

DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats

Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice

Novel fatty acid binding protein 4 (FABP4) inhibitors: Virtual screening, synthesis and crystal structure determination